Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Focal Segmental Glomerulosclerosis
NCT00040508Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in focal segmental glomerulosclerosis (FSGS), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jun 2002; status: completed.
02
Drugs
sirolimus
03
Conditions
focal segmental glomerulosclerosis (FSGS)
Beyond the preview
Go deeper on NCT00040508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040508.